// App-Quantinova.ai

: Improving Treatment Related Mortality over Time - Data from the Non-Observational Trial on Autologous Stem Cell Transplantation in Systemic Sclerosis By the EBMT Autoimmune Diseases Working Party (ADWP)

Researchers

Presenter

  • Dominique Farge

Principal Investigators

  • John A Snowden

  • Manuela Badoglio

  • Myriam Labopin

  • Hans Ulrich Scherer

  • Nicoletta Del Papa

  • Lothar Kanz

  • Marc Schmalzing

  • Thierry Martin

  • Montserrat Rovira

  • Thomas Daikeler

  • Gregory Pugnet

  • Joerg Henes

Medical Centers

  • Internal medicine and vascular patholgy; Hôpital Saint-Louis, Paris, FRA

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • EBMT Paris study office / CEREST-TC, and Department of Haematology, Saint Antoine Hospital, Paris, France, Paris, France

  • Leiden University Medical Centre, Leiden, Netherlands

  • Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milano,Italie

  • Department, University Hospital Tuebingen, Tuebingen, Germany

  • CNRS UPR 3572 "Immunopathology and Therapeutic Chemistry"/Laboratory of Excellence Medalis, Institute of Molecular and Cellular Biology (IBMC), STRASBOURG, France

  • Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, IDIBAPS, Josep Carreras Research Institute, Hospital Clinic, Barcelona, Spain

  • Department of Gynecological Oncology, University Hospital Basel, Basel, Switzerland

  • Medecine Interne; Hospitaux de Toulouse, Toulouse, France

  • Abteilung fur Hamatologie, Onkologie, Immunologie, Rheumatologie und Pulmologie, Medizinische Universitatsklinik Tubingen, Tuebingen, Germany

Locations

  • United Kingdom

  • France

  • Netherlands

  • Italy

  • Germany

  • Spain

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Central Nervous System (CNS)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Pulmonary arterial hypertension

  • Scleroderma

  • Myelodysplastic Syndrome

  • Hypertension

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • Creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Non Interventional

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved